You are here

Amgen

Amgen boots up Ohio 'smart facility' where it plans to hire 400

Fierce Pharma

Mon, 02/26/24 - 11:13 am

drug manufacturing

Amgen details rare disease ambitions following $28B Horizon acquisition

Medical Marketing and Media

Sun, 02/25/24 - 09:04 pm

Horizon Therapeutics

Colorado could cap payments for Amgen’s Enbrel

Stat

Thu, 02/22/24 - 11:47 am

autoimmune disease

Innovent's Tepezza rival one step closer to Chinese approval after phase 3 eye disease win

Fierce Biotech

Tue, 02/20/24 - 05:51 pm

Innovent Biologics

thyroid eye disease

Amgen makes progress with its Horizon prize Tepezza, but there's much work left to do

Fierce Pharma

Wed, 02/7/24 - 09:22 pm

Horizon Therapeutics

Obesity drug mania takes over Amgen’s earnings call

BioPharma Dive

Wed, 02/7/24 - 09:17 pm

Amgen earnings boosted by Horizon deal, Gilead quarterly revenue drops

Medical Marketing and Media

Tue, 02/6/24 - 11:41 pm

Gilead Sciences

Horizon Therapeutics

Amgen’s Weight-Loss Drug Candidate Shows Promise in Early Data

BioSpace

Mon, 02/5/24 - 11:04 pm

clinical trials

Amgen’s Prolia Gets FDA Boxed Warning for Risk of Severe Hypocalcemia

Xtalks

Sun, 01/28/24 - 06:28 pm

FDA adds 'boxed warning' for Amgen's Prolia

Reuters

Fri, 01/19/24 - 11:26 am

Amgen Emerges as Potential Cytokinetics Suitor as Novartis Pulls Away: Reports

BioSpace

Fri, 01/12/24 - 09:59 am

Amgen has potential to compete with established leaders in obesity drugs

Biopharma Reporter

Thu, 01/11/24 - 11:13 am

JPM24: Amgen CEO hopes to take a bite of competitive obesity market with unique approach

Fierce Pharma

Tue, 01/9/24 - 10:54 am

FDA ends busy year with three drug rejections

BioPharma Dive

Tue, 01/2/24 - 10:13 pm

Amgen's request for full approval of Lumakras in lung cancer denied by FDA

Fierce Pharma

Wed, 12/27/23 - 11:02 pm

non-small cell lung cancer

FDA starts speedy review of Amgen’s lung cancer BiTE therapy

Pharmaphorum

Thu, 12/14/23 - 09:34 am

small cell lung cancer

Amgen expands pact with Amazon to usher drug manufacturing into the AI era

Fierce Pharma

Wed, 11/29/23 - 12:06 pm

artificial intelligence

drug manufacturing

PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence

PR Newswire

Thu, 11/16/23 - 10:18 am

artificial intelligence

Amgen reports data from Sjögren’s Syndrome treatment trial

Clinical Trials Arena

Wed, 11/8/23 - 10:18 am

clinical trials

Sjögren’s syndrome

Amgen scores FDA approval for Stelara biosimilar

Pharmaceutical Technology

Wed, 11/1/23 - 10:16 pm

Pages